Patient-Enhanced Drug Discovery and Development

Patient-focused drug development (PFDD) puts patients at the center of the drug development process, ensuring their experiences, needs, and priorities shape therapeutic advancements.

By capturing patient insights throughout the drug life cycle, pharmaceutical companies can create more effective solutions while reducing development costs.

This article includes viewpoints from across industry, including Signant's Bill Byrom, on how to incorporate endpoints that are meaningful to patients, redefining drug development to prioritize the patient’s voice.

Originally printed in PharmaVoice online, March 2020.